Xell is now part of Sartorius Media Options
Gene therapy | Viral vectors | Cell therapy HEK ViP NB Medium:
base nutrient content -
Adenovirus optimized virus production
Production Boost
HEK ViP NX Medium:
Identify the most suitable cell culture media: enhanced nutrient content -
For HEK293 and other human cell lines optimized virus production
All-in-one solutions: thawing, growth,
transfection/ infection and production HEK TF Medium:
ideal for production of
From R&D to large-scale GMP production recombinant proteins
Optimized for virus/viral vector production
(e.g., Adenoviruses, AAV) and antibodies
100% chemically defined and animal-origin free
HEK GM Medium:
robust and effective
stable expression
Sartorius Xell GmbH RRR Labs Pvt Ltd (Distributor)
Bielefeld, Germany www.xell.de Mumbai, India www.rrrlabs.com
+49 521 96989 200 [email protected]
+91 22 2783 3655 [email protected]
RNI TC No. MAHENG14628 RNI NO. DELENG/2004/13061
Date of Publication - 30.9.2022 Date of Posting - 1.10.2022
Beginning-to-End Solutions for
PCR and Genomics
Get your genomics research off to the right start and stay on track with Axygen® products. From
sample preparation through PCR-based analysis—from low volume assays to high throughput
screening—our comprehensive collection of sample preparation tools ensures accuracy and precision,
while providing excellent value.
Automation Tips PCR Consumables
Pipet Tips Equipment
India t 91 124 4604000 f 91 124 4604099
[email protected]
The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.
Welcome Spike In mRNA TECH?
At least three decades in the making, mRNA vaccine technology has come a long way indeed. While many researchers and scientists worked on mRNA technology, tirelessly burning the midnight oil, a few names do come to the forefront. Dr Robert Malone, developmental biologists Paul Krieg and Douglas Melton, and molecular biologists Tom Maniatis and Michael Green have been the notable researchers who paved the way for this technology. At the same time, there are doubts raised about the safety and efficacy of mRNA vaccines. Moreover, challenges associated with the manufacture and the logistic needs of the mRNA vaccines are also some of the areas that need more focus and
innovation. Let’s dig deeper into the world of mRNA tech.
Discover the best professional documents and content resources in AnyFlip Document Base.
Search